Related references
Note: Only part of the references are listed.5-HMF Attenuates Liver Fibrosis in CCl4-Plus-Alcohol-Induced Mice by Suppression of Oxidative Stress
Xin-yue HAN et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2017)
Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands
Simone Bertini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression
Enas A. Abd El-Haleim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Treatment of alcohol use disorders in patients with alcoholic liver disease
Giovanni Addolorato et al.
JOURNAL OF HEPATOLOGY (2016)
Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft
Jin Hyoung Cho et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Peroxisome Proliferator-Activated Receptor-Gamma Agonist 4-O-Methylhonokiol Induces Apoptosis by Triggering the Intrinsic Apoptosis Pathway and Inhibiting the PI3K/Akt Survival Pathway in SiHa Human Cervical Cancer Cells
Seungyeon Hyun et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2015)
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation
Andrea Chicca et al.
JOURNAL OF NEUROINFLAMMATION (2015)
The ImageJ ecosystem: An open platform for biomedical image analysis
Johannes Schindelin et al.
MOLECULAR REPRODUCTION AND DEVELOPMENT (2015)
Validation of cyclooxygenase-2 as a direct anti-inflammatory target of 4-O-methylhonokiol in zymosan-induced animal models
Hyung Sook Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway
Ju-Hee Lee et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Review article: the endocannabinoid system in liver disease, a potential therapeutic target
P. P. Basu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
4-O-methylhonokiol Inhibits Serious Embryo Anomalies Caused by Nicotine via Modulations of Oxidative Stress, Apoptosis, and Inflammation
Chunmei Lin et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2014)
RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis
James A. Rickard et al.
CELL (2014)
Magnolia officinalis attenuates free fatty acid-induced lipogenesis via AMPK phosphorylation in hepatocytes
Min Suk Seo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Pharmacokinetics and Metabolism of 4-O-Methylhonokiol in Rats
Hyung Eun Yu et al.
PHYTOTHERAPY RESEARCH (2014)
Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis
Justine E. Roderick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity
N. J. Lee et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Cannabinoid signaling and liver therapeutics
Ariane Mallat et al.
JOURNAL OF HEPATOLOGY (2013)
Global burden of alcoholic liver diseases
Juergen Rehm et al.
JOURNAL OF HEPATOLOGY (2013)
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice
Young-Je Kim et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
Adeline Bertola et al.
NATURE PROTOCOLS (2013)
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
Juerg Gertsch et al.
JOURNAL OF NEUROINFLAMMATION (2012)
4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity
Ju Hoon Oh et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Inhibitory Effect of Ethanol Extract of Magnolia officinalis on Memory Impairment and Amyloidogenesis in a Transgenic Mouse Model of Alzheimer's Disease via Regulating β-Secretase Activity
Young-Jung Lee et al.
PHYTOTHERAPY RESEARCH (2012)
The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings
A. Mallat et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Mechanisms of Osteoclastogenesis Inhibition by a Novel Class of Biphenyl-Type Cannabinoid CB2 Receptor Inverse Agonists
Wolfgang Schuehly et al.
CHEMISTRY & BIOLOGY (2011)
Endocannabinoids in Liver Disease
Joseph Tam et al.
HEPATOLOGY (2011)
Cannabinoid CB2 Receptors Protect Against Alcoholic Liver Disease by Regulating Kupffer Cell Polarization in Mice
Alexandre Louvet et al.
HEPATOLOGY (2011)
4-O-methylhonokiol attenuated β-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase
Yong Kyung Lee et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
Eleonora Patsenker et al.
MOLECULAR MEDICINE (2011)
Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
Jonel Trebicka et al.
LIVER INTERNATIONAL (2011)
Therapeutic applications of compounds in the Magnolia family
Young-Jung Lee et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)
P. Burra et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Role of the Endocannabinoid System in Alcoholic Liver Disease
S. V. Siegmund
DIGESTIVE DISEASES (2010)
Animal Models of Alcoholic Liver Disease
Gavin E. Arteel
DIGESTIVE DISEASES (2010)
Beneficial Paracrine Effects of Cannabinoid Receptor 2 on Liver Injury and Regeneration
Fatima Teixeira-Clerc et al.
HEPATOLOGY (2010)
Magnolia officinalis Reverses Alcoholic Fatty Liver by Inhibiting the Maturation of Sterol Regulatory Element-Binding Protein-1c
Hu-Quan Yin et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Pivotal Advance:: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis
Mohanraj Rajesh et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies
Stefanie Hemmann et al.
JOURNAL OF HEPATOLOGY (2007)
Effects of magnolol (5,5'-diallyl-'2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats
Eun Jin Sohn et al.
LIFE SCIENCES (2007)
Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro
EJ Park et al.
PLANTA MEDICA (2005)
The death domain kinase RIP protects thymocytes from tumor necrosis factor receptor type 2-induced cell death
N Cusson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
